Back to top
more

CVS Health (CVS)

(Delayed Data from NYSE)

$67.77 USD

67.77
8,651,526

-0.73 (-1.07%)

Updated Apr 24, 2024 04:00 PM ET

After-Market: $67.77 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value F Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (238 out of 252)

Industry: Retail - Pharmacies and Drug Stores

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for CVS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for CVS Health Corporation falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 11,455 15,723 12,525 10,854 8,056
Receivables 35,227 27,276 24,431 21,742 19,617
Notes Receivable 0 0 0 0 0
Inventories 18,025 19,090 17,760 18,496 17,516
Other Current Assets 3,151 3,593 5,292 5,277 5,113
Total Current Assets 67,858 65,682 60,008 56,369 50,302
Net Property & Equipment 13,183 12,873 12,896 12,606 12,044
Investments & Advances 23,019 21,096 23,025 20,812 17,314
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 120,506 102,904 108,147 110,694 112,870
Deposits & Other Assets 7,910 7,848 9,801 9,505 9,059
Total Assets 249,728 228,275 232,999 230,715 222,449
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 14,897 14,838 12,544 11,138 10,492
Current Portion Long-Term Debt 2,972 1,778 4,205 5,440 3,781
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 22,189 18,745 17,670 14,243 12,133
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 37,390 32,697 31,742 29,558 25,301
Total Current Liabilities 79,189 69,736 67,807 62,017 53,303
Mortgages 0 0 0 0 0
Deferred Taxes/Income 4,311 3,880 6,270 6,794 7,294
Convertible Debt 0 0 0 0 0
Long-Term Debt 58,638 50,476 51,971 59,207 64,699
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 14,920 16,068 13,393 14,239 14,057
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 173,092 156,960 157,618 161,014 158,279
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 48,992 48,193 47,377 46,513 45,972
Capital Surplus 0 0 0 0 0
Retained Earnings 61,604 56,145 54,906 49,640 45,108
Other Equity -122 -1,165 1,271 1,726 1,325
Treasury Stock 33,838 31,858 28,173 28,178 28,235
Total Shareholder's Equity 76,636 71,315 75,381 69,701 64,170
Total Liabilities & Shareholder's Equity 249,728 228,275 232,999 230,715 222,449
Total Common Equity 76,636 71,315 75,381 69,701 64,170
Shares Outstanding 1,286.90 1,313.90 1,320.00 1,308.90 1,300.90
Book Value Per Share 59.55 54.28 57.11 53.25 49.33

Fiscal Year End for CVS Health Corporation falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 11,455 16,188 16,887 17,720
Receivables NA 35,227 32,927 29,546 28,331
Notes Receivable NA 0 0 0 0
Inventories NA 18,025 17,954 17,291 18,263
Other Current Assets NA 3,151 3,074 4,032 4,392
Total Current Assets NA 67,858 70,143 67,756 68,706
Net Property & Equipment NA 13,183 13,022 13,001 12,872
Investments & Advances NA 23,019 21,667 22,114 21,612
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 120,506 120,885 121,378 110,425
Deposits & Other Assets NA 7,910 8,025 8,119 8,055
Total Assets NA 249,728 251,306 250,071 239,330
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 14,897 14,874 13,367 12,527
Current Portion Long-Term Debt NA 2,972 2,132 2,402 1,778
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 22,189 22,571 22,831 21,515
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 37,390 40,235 38,900 37,555
Total Current Liabilities NA 79,189 81,553 79,206 75,054
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 4,311 4,250 4,588 4,095
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 58,638 59,782 61,419 56,450
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 14,770 15,247 15,580
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 173,092 176,796 177,069 167,750
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 48,992 48,829 48,649 48,306
Capital Surplus NA 0 0 0 0
Retained Earnings NA 61,604 60,343 58,868 57,753
Other Equity NA -122 -831 -582 -677
Treasury Stock NA 33,838 33,831 33,933 33,802
Total Shareholder's Equity NA 76,636 74,510 73,002 71,580
Total Liabilities & Shareholder's Equity NA 249,728 251,306 250,071 239,330
Total Common Equity 0 76,636 74,510 73,002 71,580
Shares Outstanding 1,258.40 1,286.90 1,286.90 1,284.40 1,282.00
Book Value Per Share 0.00 59.55 57.90 56.84 55.83